'Night Vision' Contacts Are Here, Scientists Say
In the 1980s, people wore their sunglasses at night. In the 2020s, people will be able to wear ultra advanced contact lenses that grant the wearer 'super-vision,' according to researchers. In a new report from Live Science, the new super contacts will allow wearers to see infrared wavelengths that are usually invisible to the human eye. Talk about a major upgrade.
In a press release, researcher and senior author of the paper about the contacts, Tian Xue, said that the contacts will have a wide variety of applications.
'Our research opens up the potential for non-invasive wearable devices to give people super-vision,' said Tian Xue, a neuroscientist at the University of Science and Technology of China. 'There are many potential applications right away for this material. For example, flickering infrared light could be used to transmit information in security, rescue, encryption or anti-counterfeiting settings.'
Right now though, the contact lenses are still purely in the realm of scientific study. They have been tested on both mice and humans. The tests so far have proved that without the lenses, there were certain things humans simply could not see.
'It's totally clear cut: without the contact lenses, the subject cannot see anything, but when they put them on, they can clearly see the flickering of the infrared light,' said Xue. 'We also found that when the subject closes their eyes, they're even better able to receive this flickering information, because near-infrared light penetrates the eyelid more effectively than visible light, so there is less interference from visible light.'
If you want to read more about the science involved, you can check out more details here.
'Night Vision' Contacts Are Here, Scientists Say first appeared on Men's Journal on May 23, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Using an AI chatbot dulls thinking, neural scans show
People who use artificial intelligence chatbots to help them write risk losing their full powers of cognition, if brain scans carried out at Massachusetts Institute of Technology are anything to go by. After running electroencephalography (EEG) scans to assess "cognitive load" on participants, researchers found AI users "consistently underperformed at neural, linguistic and behavioral levels." Divided into three groups, the test subjects worked on essays either by themselves, with access to online search or by using large language model (LLM) AI assistance. "Cognitive activity scaled down in relation to external tool use," the MIT team found. Of the three groups, people who used tools such as ChatGPT "displayed the weakest connectivity" and struggled to recall or quote their work, the team said, writing up their findings in a 208-page journal paper. The "brain only" group "exhibited the strongest, most distributed networks," the tests showed, while participants who used search engines were found to be somewhere in between. Those who leaned on AI showed what the team described as "reduced alpha and beta connectivity" - findings that indicated "under-engagement" by brains using bots. In contrast, people who had to think through their assignment without leaning on AI demonstrated "higher memory recall" and the activation of certain parts of the brain, the team found. "While LLMs offer immediate convenience, our findings highlight potential cognitive costs," they said, warning that the results "raise concerns about the long-term educational implications of LLM reliance and underscore the need for deeper inquiry into AI's role in learning." The findings follow the publication in April of a survey of over 300 "knowledge workers" by Microsoft, the maker of Copilot AI systems, in which respondents indicated "reductions in cognitive effort" while using chatbots. "Used improperly, technologies can and do result in the deterioration of cognitive faculties that ought to be preserved," the researchers warned. AI use at work has doubled over the past two years, according to a recently published Gallup survey. "27% of white-collar employees report frequently using AI at work, an increase of 12 percentage points since 2024," the pollster reported.
Yahoo
8 hours ago
- Yahoo
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea, June 23, 2025--(BUSINESS WIRE)--NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, "Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives." NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on Contacts NEL Animal Cardiovascular CenterYoon il-yong+82-31-421-7579heart@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
8 hours ago
- Associated Press
NEL Animal Cardiovascular Center Achieves World's First Surgical Correction of Complex VSD in Canine Patient
ANYANG, South Korea--(BUSINESS WIRE)--Jun 22, 2025-- NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world's first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This press release features multimedia. View the full release here: NEL Animal Cardiovascular Center's medical staff performing surgical correction of a complex ventricular septal defect (VSD) in a canine patient (Photo: NEL Animal Cardiovascular Center) This veterinary milestone is highly significant, as it marks the first such case not only in Korea but also globally, with no previous reports of successful surgical treatment for complex VSDs. The patient was diagnosed with a unique form of VSD—a single, continuous defect extending from the perimembranous to the subarterial region (Perimembranous VSD extending into subarterial region). Given that there had been no prior successful surgical cases even for typical VSDs in veterinary medicine, this breakthrough greatly expands the possibilities for surgical treatment of congenital heart disease in Korea's veterinary cardiac surgery field. Over the past year, NEL's cardiac surgery team has gained experience through more than 50 open-heart surgeries using cardiopulmonary bypass. Based on this expertise, the team developed a thorough surgical plan. During the procedure, the complex VSD involving both membranous and subarterial regions was confirmed. The team performed incisions in the right atrium and pulmonary artery, successfully closing the defect with a bovine pericardial patch. Immediately after surgery, the left-to-right shunt was completely resolved, and the risk of progressive regurgitation due to aortic valve prolapse was eliminated. The patient's cardiac function recovered to near-normal levels, and the long-term prognosis is considered highly favorable. Subarterial VSDs are particularly dangerous due to the risk of aortic valve prolapse and severe regurgitation, making early surgical intervention crucial. The success of this surgery offers new hope for animals with congenital heart defects, demonstrating the potential for a surgical cure. Dr. Tae-Heum Um, Director of NEL Animal Cardiovascular Center, stated, 'Although this was a complex defect, thorough discussion and preparation among our medical team led to a successful outcome. We will continue our efforts so that more animals with congenital heart disease can lead healthy and normal lives.' NEL Animal Cardiovascular Center is preparing an academic analysis and official report on this case, and sincerely hopes that this achievement contributes to the advancement of veterinary cardiac surgery not only in Korea, but also across Asia. View source version on CONTACT: NEL Animal Cardiovascular Center Yoon il-yong +82-31-421-7579 [email protected] KEYWORD: ASIA PACIFIC SOUTH KOREA INDUSTRY KEYWORD: CARDIOLOGY VETERINARY BIOTECHNOLOGY PETS SURGERY HEALTH HEALTH TECHNOLOGY CONSUMER SOURCE: NEL Animal Cardiovascular Center Copyright Business Wire 2025. PUB: 06/22/2025 08:00 PM/DISC: 06/22/2025 07:59 PM
